Submitted:
12 August 2024
Posted:
13 August 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Results
2.1. Demographic Characteristics of CL Patients
2.2. Clinical Polymorphism of CL Patients
2.3. Magnitude of Malnutrition and Associated Factors
2.4. Burden of Cutaneous Leishmaniasis and Malnutrition by Districts
2.5. Cutaneous Leishmaniasis Chronicity and Associated Factors
3. Discussion
4. Materials and Methods
- Study area and period
- b
- Study design, period, and data collection
- c
- Source population
- d
- Study population
- e
- Inclusion and Exclusion criteria
- f
- Diagnosis of CL cases
- g
- Determination of nutritional status of CL cases
- Clinical polymorphism: It is referring the CL patients, the lesion site/ where the lesion was found, and based on that classifications are made as Localized, Mucosal, or diffused, and the treatment cycle, as new or repeat.
- Ethics approval
5. Conclusion
Supplementary Materials
Author Contributions
Funding
Informed Consent Statement
Data Availability Statement
Acknowledgment
Conflicts of Interest
References
- Arango Duque, G.; Descoteaux, A. Leishmania survival in the macrophage: where the ends justify the means. Curr Opin Microbiol. 2015, 26, 32–40. [Google Scholar] [CrossRef] [PubMed]
- Scorza, B.M.; Carvalho, E.M.; Wilson, M.E. Cutaneous manifestations of human and murine Leishmaniasis. International Journal of Molecular Sciences 2017, 18, 1296. [Google Scholar] [CrossRef] [PubMed]
- Sierra Franco, A.; Talamante Madrid, M.J.; Espejo Nuño, R.M.; Davila Baeza, D.A.; Espinoza Hernández, M.Y.; Cano Muñoz, E.; Boza Medrano, M.E. Cutaneous leishmaniasis: an underdiagnosed entity in the first contact. Int J Res Dermatol. 2023, 9, 145–149. [Google Scholar] [CrossRef]
- Desjeux, P. The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg. 2001, 95, 239–243. [Google Scholar] [CrossRef] [PubMed]
- Aronson, N.; Cutaneous leishmaniasis: Clinical manifestations and diagnosis. Up-to-date evidence-based Clinical Decision Support. Available online: https://www.uptodate (accessed on 21 January 2023).
- Burnett M, W. Cutaneous leishmaniasis. J Spec Oper Med. 2015, 15, 128–129. [Google Scholar] [CrossRef] [PubMed]
- Markle, W.H.; Makhoul, K. Cutaneous Leishmaniasis: Recognition and Treatment. American Family Physician 2004, 69, 1457. [Google Scholar]
- Kamb, M.; Roy, S.; Cantey, P. Leishmaniasis, Cutaneous. In: CDC Yellow Book 2024 Travel-Associated Infections & Diseases. Vancouver; 2024.
- Berman, J.D.; Davies, C.R.; Saravia, N.G. “Advances in Leishmaniasis” 2005, 366, 1561–1577. [CrossRef]
- Louzir, H.; Melby, P.C.; Salah, A.B. , et al. Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major. J Infect Dis. 1998, 177, 1687–1695. [Google Scholar] [CrossRef] [PubMed]
- Reithinger, R.; Dujardin, J.-C.; Louzir, H. , et al. Cutaneous leishmaniasis. Lancet Infect Dis. 2007, 7, 581–596. [Google Scholar] [CrossRef] [PubMed]
- Revillard, J.; Cozon, G. Experimental models, and mechanisms of immune deficiencies of nutritional origin. Food Addit Contam. 1990, 7, S82–S86. [Google Scholar] [CrossRef]
- Zavitsanou, A.; Koutis, C.; Babatsikou, F. Leishmaniasis: An overlooked public health concern. HSJ - Health Science Journal, 2008; 2. [Google Scholar]
- Chandra, R.K. Nutrition and the immune system: an introduction. Am J ClinNutr. 1997, 66, 460–463. [Google Scholar] [CrossRef]
- Feldman, M.; Friedman, L.; Brandt, L. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 9th ed. Philadelphia: Saunders; 2010.
- Nutrition Assessment, Counseling, and Support (NACS): A User’s Guide—Module 2: Nutrition Assessment and Classification, Version 2. Washington, DC: FHI 360/FANTA. 2016.
- Oliveira, A.G.L.; Brito, P.D.; Schubach, A.O.; Oliveira, R.V.C.; Saheki, M.N.; Lyra, M.R.; Salgueiro, M.M.; Terceiro, B.F.; Pimentel, M.I.F.; Vasconcellos, E.C.; Valete-Rosalino, C.M. Influence of the nutritional status in the clinical and therapeutical evolution in adults and elderly with American Tegumentary Leishmaniasis. Acta Tropica. 2013, 128, 36–40. [Google Scholar] [CrossRef]
- Blackburn, G.L.; Bistrian, B.R.; Maini, B.S.; Schlamm, H.T.; Smith, M.F. Nutritional and metabolic assessment of the hospitalized patients. Journal of Parenteral and Enteral Nutrition 1977, 1, 11–22. [Google Scholar] [CrossRef] [PubMed]
- Lockard, R.D.; Wilson, M.E.; Rodríguez, N.E. Sex-Related Differences in Immune Response and Symptomatic Manifestations to Infection with Leishmania Species. J Immunol Res. 2019, 2019, 4103819. [Google Scholar] [CrossRef]
- Anstead, G.M.; Chandrasekar, B.; Zhao, W.; Yang, J.; Perez, L.E.; Malnutrition, P.C. Alters the Innate Immune Response and Increases Early Visceralization following Leishmania donovani Infection. Infect Immun. 2001, 69, 4709–4718. [Google Scholar] [CrossRef]
- Ethiopian nutrition profile: USAID, updated on May 2023.
- Federal Democratic Republic of Ethiopia. (2016). Seqota Declaration Implementation Plan (2016-2030): Summary program approach document. Vancouver:.
- Yohannes, M.; Abebe, Z.; Boelee, E. Prevalence and environmental determinants of cutaneous leishmaniasis in rural communities in Tigray, northern Ethiopia. PLoS Negl Trop Dis. 2019, 13, 1–14. [Google Scholar] [CrossRef] [PubMed]
- Neway, S.; Yeshitila, B.; Mebrat, B. , et al. Prevalence of cutaneous leishmaniasis in Alert Center, retrospective analysis, Addis Ababa. J Health Syst Policies. 2021, 3, 110–121. [Google Scholar] [CrossRef]
- Yizengaw, E.; Nibret, E.; Yismaw, G.; Gashaw, B.; Tamiru, D.; Munshea, A. , et al. Cutaneous leishmaniasis in a newly established treatment center in the Lay Gayint district, Northwest Ethiopia. Skin Health Dis. 2023, 3, e229. [Google Scholar] [CrossRef] [PubMed]
- Wondiye, K.; Asseffa, N.A.; Gemebo, T.D.; Astawesegn, F.H. Predictors of undernutrition among the elderly in Sodo zuriya district Wolaita zone, Ethiopia. BMC Nutrition 2019, 5, 50. [Google Scholar] [CrossRef]
- Legesse, M.; Abebe, Z.; Woldie, H. Chronic energy deficiency and associated factors among the older population in Ethiopia: A community-based study. PLoS ONE 2019, 14, e0214861. [Google Scholar] [CrossRef]
- Abdu, A.O.; Yimamu, I.D.; Kahsay, A.A. Predictors of malnutrition among older adults aged above 65 years in eastern Ethiopia: neglected public health concern. BMC Geriatr 2020, 20, 497. [Google Scholar] [CrossRef]
- Yisak, H.; Tadege, M.; Ambaw, B.; Ewunetei, A. Prevalence and Determinants of Stunting, Wasting, and Underweight Among School-Age Children Aged 6–12 Years in South Gondar Zone, Ethiopia. Pediatr. Health Med. Ther. 2021, 12, 23–33. [Google Scholar] [CrossRef] [PubMed]
- Nweze, J.A.; Nweze, E.I.; Onoja, U.S. Nutrition, malnutrition, and leishmaniasis. Nutrition 2020, 73, 110712. [Google Scholar] [CrossRef]
- Udaya Kumar, V.; Favas, K.T.M.; Sharma, A.; Bisht, P.; Dhingra, S.; Ravichandiran, V.; Ramesh, M.; Murti, K. The Possible Role of Selected Vitamins and Minerals in the Therapeutic Outcomes of Leishmaniasis. Biol Trace Elem Res. 2022. [CrossRef]
- Moya-Salazar, J.; Pasco, I.A.; Cañari, B.; Contreras-Pulache, H. Cutaneous Leishmaniasis Associated With the Level of Poverty of the Andean Rural Population: A Five-Year Single-Center Study. Electron J Gen Med. 2021, 18. [Google Scholar] [CrossRef] [PubMed]
- Boelaert, M.; Meheus, F.; Sanchez, A.; Singh, S.P.; Vanlerberghe, V.; Picado, A. , et al. The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India. Trop Med Int Health 2009, 14, 639–644. [Google Scholar] [CrossRef]
- Wintergerst, E.S.; Maggini, S.; Hornig, D.H. Contribution of selected vitamins and trace elements to immune function. Ann Nutr Metab. 2007, 51, 301–323. [Google Scholar] [CrossRef] [PubMed]
- Tegegne, B.; Yimer, M.; Ejigu, K.; Alemu, G.; Estifanos, F. Eight-Year Trend Analysis of Cutaneous Leishmaniasis Cases in West Amhara Region Referred to Amhara Public Health Institute Northwest, Ethiopia: A Retrospective Study. BioMed Res Int. 2022, 6562092. [Google Scholar] [CrossRef] [PubMed]
- Tegegne, B.; Yimer, M.; G/eyesus, T.; Ayal, A.; Yimer, M. Short reports on cutaneous leishmaniasis outbreak investigation in Ankesha-Guagsa district, Amhara region, Northwest Ethiopia. Trop Doct. 2022, 52, 131–133. [Google Scholar] [CrossRef]
- Shita, E.Y.; Semegn, E.N.; Wubetu, G.Y.; Abitew, A.M.; Andualem, B.G.; Alemneh, M.G. Prevalence of Leishmania RNA virus in Leishmania parasites in patients with tegumentary leishmaniasis: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2022, 16, e0010427. [Google Scholar] [CrossRef]
- Machado-Coelho, G.L.; Caiaffa, W.T.; Genaro, O.; Magalhães, P.A.; Mayrink, W. Risk factors for mucosal manifestation of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 2005, 99, 55–61. [Google Scholar] [CrossRef]
- Maciel, B.L.L.; Lacerda, H.G.; Queiroz, J.W.; Galvao, J.; Pontes, N.N.; Dimenstein, R.; McGowan, S.E.; Pedrosa, L.F.C.; Jerônimo, S.M.B. Association of Nutritional Status with the Response to Infection with Leishmania chagasi. Am. J. Trop. Med. Hyg. 2008, 79, 591–598. [Google Scholar] [CrossRef] [PubMed]
- Carrillo, E.; Jimenez, M.; Sanchez, C.; Cunha, J.; Martins, C.M. , et al. Protein Malnutrition Impairs the Immune Response and Influences the Severity of Infection in a Hamster Model of Chronic Visceral Leishmaniasis. PLoS ONE 2014, 9, e89412. [Google Scholar] [CrossRef] [PubMed]
- Guzman-Rivero, M.; Rojas, E.; Verduguez-Orellana, A.; Pardo, H.; Torrico, M.C.; Cloetens, L.; Akesson, B.; Sejas, E. Nutritional status in patients with cutaneous leishmaniasis and a study of the effects of zinc supplementation together with antimony treatment. Food Nutr Res. 2014, 58, 23353. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Collins, C.E.; Kershaw, J.; Brockington, S. Effect of nutritional supplements on wound healing in home-nursed elderly: A randomized trial. Nutrition 2005, 21, 147–155. [Google Scholar] [CrossRef]
- Merdekios, B.; Pareyn, M.; Tadesse, D.; Getu, S.; Admassu, B.; Girma, N.; Leirs, H.; Van geertruyden, J.P.; van Griensven, J. Detection of Cutaneous Leishmaniasis Foci in South Ethiopia. 2021.
| Variables | Frequency | % | χ2:(df):p-value |
| Age (year) | |||
| ≤18 | 89 | 41 |
77.7:(3):0.000 |
| 19-40 | 82 | 38 | |
| 41-60 | 35 | 16 | |
| >60 | 11 | 5 | |
| Total | 217 | ||
| Sex | |||
| F | 59 | 27 |
45:(1):0.000 |
| M | 158 | 73 | |
| Total | 217 | ||
| Variables | Frequency | % | χ2:(df):p-value |
| Chronicity of the disease | |||
| 0-6month | 73 | 36 |
7:(1):0.000 |
| ˃6month | 129 | 64 | |
| Total | 202 | ||
| CL category | |||
| LCL | 176 | 81 |
83:(9):0.000 |
| MCL | 41 | 19 | |
| Total | 217 | ||
| Lesion size | |||
| <4cm2 | 120 | 58 |
5:(1):0.02 |
| ≥4cm2 | 87 | 42 | |
| Total | 207 | ||
| Microscopic examination | |||
| Positive | 199 | 97 | 181:(1):0.000 |
| Negative | 6 | 3 | |
| Total | 205 | ||
| Treatment history | |||
| New | 204 | 94 | 168: (1):0.000 |
| Repeat (recurrent) | 13 | 6 | |
| Total | 217 | ||
| Variables | Malnutrition |
χ2:(df):p-value |
||
| Yes (%) | No (%) | |||
| Age category | ||||
| ≤18 | 23 (27) | 63 (73) |
9.8:(3):0.02 |
|
| 19-40 | 13 (16) | 69 (84) | ||
| 41-60 | 6 (17) | 29 (83) | ||
| >60 | 6 (55) | 5 (45) | ||
| Total | 48 | 166 | ||
| Sex category | ||||
| F | 16 (27) | 43 (73) |
1.1:(1):0.27 |
|
| M | 32 (20) | 126 (80) | ||
| Total | 48 | 169 | ||
| Duration of illness | ||||
| 0-6month | 21(29) | 52 (71) |
3.8:(1):0.03 |
|
| ˃6month | 22 (17) | 107(83) | ||
| Total | 43 | 159 | ||
| Lesion size | ||||
| <4cm2 | 27(22.5) | 93 (77.5) | 0.26:(1):0.60 | |
| ≥4cm2 | 17(20) | 70 (80) | ||
| Total | 44 | 163 | ||
| CL-type | ||||
| LCL | 36 (20) | 140 (80) | 1.5:(1):0.22 | |
| MCL | 12 (30) | 29 (70) | ||
| Total | 48 | 169 | ||
| Treatment History | New | 43 (21) | 161 (79) | 2.2:(2):0.3 |
| Repeat/recurrent | 5 (38.5) | 8 (61.5) | ||
| Total | 48 | 169 | ||
| Microscopy result | ||||
| P | 45 (23) | 154 (77) | 1.7:(1):0.18 | |
| N | 0 | 6 (100) | ||
| Total | 48 | 160 | ||
| Variables | Nutritional status | Total | χ2:(df):p-value | ||
| Sever (%) | Moderate (%) | Normal (%) | |||
| Treatment history |
2.2(2):0.3 |
||||
| New | 11 (5.4) | 32 (15.7) | 161(78.9) | 204 (100) | |
| Recurrent | 1 (7.7) | 4 (30.8) | 8 (61.5) | 13 (100) | |
| Total | 12 | 36 | 169 | 217 | |
| CL type |
2.2(2):0.3 |
||||
| LCL | 8 (4.5) | 28(16) | 140 (79.5) | 176 (100) | |
| MCL | 4 (10) | 8 (19.5) | 29 (70.7) | 41(100) | |
| Total | 12 | 36 | 269 | 217 | |
| Lesion size |
2.5(2):0.2 |
||||
| <4cm2 | 3 (2.5) | 24 (20) | 93 (77.5) | 120 (100) | |
| ≥4cm2 | 5 (6) | 12 (14) | 70 (80) | 87 (100) | |
| Total | 8 | 36 | 163 | 207 | |
| Age | |||||
| ≤18 | 3 (3.4) | 20 (22.4) | 66 (74.2) | 89 (100) |
14.7(6):0.02 |
| 19-40 | 6 (7.3) | 7 (8.5) | 69 (84.2) | 82 (100) | |
| 41-60 | 2 (5.8) | 4 (11.4) | 29 (82.8) | 35 (100) | |
| >60 | 1 (9) | 5 (45.5) | 5 (45.5) | 11 | |
| Total | 12 | 36 | 169 | 217 | |
| Microscopy | |||||
| Positive | 10 | 35 | 154 | 199 |
1.7(2):0.4 |
| Negative | 0 | 0 | 6 | 6 | |
| Total | 10 | 35 | 160 | 205 | |
| Zone: Administrative area | Number of CL reporting districts | Case number | Total CL cases (Not screened for nutrition) | |
| CL: Malnourished | CL: Normal for nutrition | |||
| South Gondar | 17 | 16 (11.7%) | 121 (88.3%) | 354 |
| Waghimra | 8 | 32 (25%) | 96 (75%) | 116 |
| Total | 25 | 48 | 217 | 470 |
| Variables | Onset of disease/chronicity/time of first visit (month) | χ2:(df):p-value | ||||
| Month | 0-6 (%) | 7-<13(%) | 13-24(%) | >24 (%) | Total | |
| Age | ||||||
| ≤18 | 25 (29) | 52 (60.5) | 4 (4.5) | 5 (6) | 86 (100) | 14 (9) 0.1 |
| 19-40 | 34 (46) | 37 (50) | 2 (2.7) | 1 (1.3) | 74 (100) | |
| >40 | 13 (31) | 23 (54.7) | 1 (2.3) | 5 (12) | 42 (100) | |
| Total | 72 | 112 | 7 | 11 | 202 | |
| Nutrition status | ||||||
| SAM | 5 (50) | 5 (50) | 0 (0) | 0 (0) | 10 (100) | 6.4 (6) 0.3 |
| MAM | 16 (48.5) | 16 (48.5) | 1 (3) | 0 (0) | 33 (100) | |
| Normal | 51 (32) | 91 (57) | 6 (4) | 11 (7) | 159 (100) | |
| Total | 72 | 112 | 7 | 11 | 202 | |
| Lesion size | ||||||
| <4cm2 | 56 (48) | 57(49) | 0 (0) | 3 (3) | 116 (100) | 28 (3) 0.0001 |
| ≥4cm2 | 14 (17.5) | 52 (65) | 6 (7.5) | 8 (10) | 80 (100) | |
| Total | 70 | 109 | 6 | 11 | 196 | |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).